Eris Lifesciences to host investor meetings in Mumbai

Eris Lifesciences Limited will hold in-person one-on-one and group meetings with investors in Mumbai on September 16 and 17, 2025. This forms part of a non-deal roadshow, organized in collaboration with Ambit Capital and Investec. The announcement, dated September 11, 2025, was made in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

The company emphasized that the scheduled meetings are indicative and may be subject to changes due to unforeseen developments. During these interactions, Eris Lifesciences will refer to publicly available documents. No unpublished price-sensitive information (UPSI) is intended for discussion.

The intimation was addressed to the BSE Limited and the National Stock Exchange of India Limited. Milind Talegaonkar, company secretary & compliance officer, digitally signed the announcement on behalf of Eris Lifesciences Limited.